ES2784351T3 - Métodos de discriminación entre el VIH-1 y vectores de lentivíricos - Google Patents

Métodos de discriminación entre el VIH-1 y vectores de lentivíricos Download PDF

Info

Publication number
ES2784351T3
ES2784351T3 ES16729099T ES16729099T ES2784351T3 ES 2784351 T3 ES2784351 T3 ES 2784351T3 ES 16729099 T ES16729099 T ES 16729099T ES 16729099 T ES16729099 T ES 16729099T ES 2784351 T3 ES2784351 T3 ES 2784351T3
Authority
ES
Spain
Prior art keywords
nucleic acid
hiv
ltr
cal
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16729099T
Other languages
English (en)
Spanish (es)
Inventor
Kazuo Suzuki
Anthony Dominic Kelleher
Geoffrey Phillip Symonds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewSouth Innovations Pty Ltd
St Vincents Hospital Sydney Ltd
CSL Gene Therapy Pty Ltd
CSL Behring Gene Therapy Inc
Original Assignee
NewSouth Innovations Pty Ltd
St Vincents Hospital Sydney Ltd
Calimmune Australia Pty Ltd
Calimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NewSouth Innovations Pty Ltd, St Vincents Hospital Sydney Ltd, Calimmune Australia Pty Ltd, Calimmune Inc filed Critical NewSouth Innovations Pty Ltd
Application granted granted Critical
Publication of ES2784351T3 publication Critical patent/ES2784351T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES16729099T 2015-05-18 2016-05-16 Métodos de discriminación entre el VIH-1 y vectores de lentivíricos Active ES2784351T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562163327P 2015-05-18 2015-05-18
PCT/US2016/032767 WO2016187151A1 (en) 2015-05-18 2016-05-16 Methods of discriminating between hiv-1 and lentiviral vectors

Publications (1)

Publication Number Publication Date
ES2784351T3 true ES2784351T3 (es) 2020-09-24

Family

ID=56121165

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16729099T Active ES2784351T3 (es) 2015-05-18 2016-05-16 Métodos de discriminación entre el VIH-1 y vectores de lentivíricos

Country Status (10)

Country Link
US (2) US10240214B2 (enExample)
EP (1) EP3283658B1 (enExample)
JP (1) JP2018516594A (enExample)
CN (1) CN108026593A (enExample)
AU (1) AU2016265839A1 (enExample)
CA (1) CA2986133A1 (enExample)
DK (1) DK3283658T3 (enExample)
ES (1) ES2784351T3 (enExample)
HK (1) HK1247965A1 (enExample)
WO (1) WO2016187151A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3414340B1 (en) * 2016-02-12 2023-08-09 CureVac SE Method for analyzing rna
US11920174B2 (en) 2016-03-03 2024-03-05 CureVac SE RNA analysis by total hydrolysis and quantification of released nucleosides
US20210332448A1 (en) * 2020-03-09 2021-10-28 Janssen Pharmaceutica Nv Compositions and methods for quantifying integration of recombinant vector nucleic acid
CN111961760A (zh) * 2020-09-02 2020-11-20 苏州市第五人民医院 基于ddPCR自动化检测HIV-1的引物组、探针组、试剂盒及用途
CN114134251B (zh) * 2020-09-04 2025-04-01 上海赛比曼生物科技有限公司 一种快速检测慢病毒载体滴度的方法
CN112210625A (zh) * 2020-11-02 2021-01-12 中山大学达安基因股份有限公司 定量检测人类免疫缺陷病毒1型dna载量的试剂盒及方法
CN113151587A (zh) * 2021-01-28 2021-07-23 云舟生物科技（广州）有限公司 一种慢病毒滴度检测引物、试剂盒及检测方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000159A (en) 1974-06-28 1976-12-28 Phillips Petroleum Company Preparation of n,n-disubstituted thioamides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5176995A (en) 1985-03-28 1993-01-05 Hoffmann-La Roche Inc. Detection of viruses by amplification and hybridization
ATE282716T1 (de) * 1989-07-11 2004-12-15 Gen Probe Inc Verfahren zur amplifikation von nukleinsäuresequenzen
WO1992020813A1 (en) * 1991-05-17 1992-11-26 Dana Farber Cancer Institute Assays for factors affecting circularization of dna, assays for factors affecting dna integration, factors, and uses thereof
US5578444A (en) * 1991-06-27 1996-11-26 Genelabs Technologies, Inc. Sequence-directed DNA-binding molecules compositions and methods
US5576176A (en) * 1994-03-03 1996-11-19 The Regents Of The University Of California Marker and an assay for detection and monitoring of human immunodeficiency virus latency and activation
US20030104576A1 (en) * 1994-10-07 2003-06-05 Jonathan W. Nyce Dna construct, composition, formulations & methods for making the construct & for modulating expression
DE19907485B4 (de) * 1999-02-12 2008-01-17 Strathmann Ag & Co. Virus-Vakzine
US8889844B2 (en) * 2005-08-16 2014-11-18 Takara Bio Inc. Nucleic acid for treatment or prevention of immunodeficiency virus infection
DK3329772T3 (da) 2009-07-15 2020-01-27 Calimmune Inc Dobbeltvektor til inhibering af human immundefektvirus
WO2011011584A1 (en) 2009-07-24 2011-01-27 Immune Design Corp Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein
WO2012141984A1 (en) * 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
CA2882020A1 (en) * 2012-08-16 2014-02-20 NVS Technologies, Inc. Assay methods and systems
CN103882062A (zh) * 2014-03-13 2014-06-25 山西大学 慢病毒干扰载体pll3.7-Neo及其构建方法

Also Published As

Publication number Publication date
EP3283658A1 (en) 2018-02-21
EP3283658B1 (en) 2020-03-11
US11008630B2 (en) 2021-05-18
HK1247965A1 (zh) 2018-10-05
US10240214B2 (en) 2019-03-26
CA2986133A1 (en) 2016-11-24
CN108026593A (zh) 2018-05-11
WO2016187151A1 (en) 2016-11-24
DK3283658T3 (da) 2020-05-18
US20190153551A1 (en) 2019-05-23
AU2016265839A1 (en) 2017-12-07
JP2018516594A (ja) 2018-06-28
US20180066325A1 (en) 2018-03-08

Similar Documents

Publication Publication Date Title
ES2784351T3 (es) Métodos de discriminación entre el VIH-1 y vectores de lentivíricos
ES2445495T3 (es) Cebadores de ácido nucleico y sondas para detectar VIH-1 y VIH-2
ES2639568T3 (es) Método para diseñar un régimen farmacológico para pacientes infectados con el VIH
ES2970989T3 (es) Procedimientos de detección de VIH
Contreras-Galindo et al. A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens
CN115768899A (zh) 用于定量重组载体核酸整合的组合物和方法
US20140378526A1 (en) Design of nucleic acid binding molecules with non-watson crick and non-canonical pairing based on artificial mutation consensus sequences to counter escape mutations
JP5553323B2 (ja) Ｈｉｖ検出キット、及びｈｉｖ検出方法
CN118591639A (zh) 通过环介导等温扩增检测靶标核酸点突变的方法
EP1960554B1 (en) Methods, plasmid vectors and primers for assessing hiv viral fitness
ES2675725T3 (es) Composiciones y procedimientos para la hibridación de ácidos nucleicos
Thomas et al. Comparative analysis and generation of a robust HIV-1 DNA quantification assay
Bagasra RNAi as an antiviral therapy
KR100440852B1 (ko) 레트로바이러스에 특이적인 올리고뉴클레오티드 프라이머및 이를 이용한 레트로바이러스 농도 측정방법
CN119320846A (zh) 基于CRISPR-cas12a/cas13a同时检测乙型肝炎病毒DNA和RNA的检测方法及应用
KR102722347B1 (ko) 유전자가위 기반 중증열성혈소판감소증후군 바이러스의 신속 검출
CN103667521A (zh) 一组用于检测虹彩病毒的引物及检测方法
MX2007010387A (es) Deteccion de virus de la forma muy virulenta de la bursitis infecciosa.
JP2007135469A (ja) 核酸増幅方法
Sertznig Interferon-induced alteration of the cellular splicing machinery and its influence on HIV-1 replication
JP6368302B2 (ja) Ｈｉｖウイルスのｄｎａの異なるウイルス形を定量する方法
HK40090233A (zh) 用於定量重组载体核酸整合的组合物和方法
Gamez Development of the Molecular Biology of HIV-Seek: A Novel Approach to Characterizing Latently Infected CD4+ T Cells
Ruggiero et al. Development of a Sensitive qPCR Assay for Quantification of Integrated HIV-1 DNA in Peripheral Blood Mononuclear Cells
JP2006320237A (ja) 核酸増幅方法